Status:
COMPLETED
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Diadexus, Inc.
University of California, Davis
Conditions:
Cerebrovascular Accident
Eligibility:
All Genders
Brief Summary
Transient ischemic attack (TIA) is a transient neurological deficit (speech disturbance, weakness…), caused by temporary occlusion of a brain vessel by a blood clot that leaves no lasting effect. TIA...
Detailed Description
Patients with a clinical suspicion of TIA seen at the Stanford Emergency Department, will be admitted to the Clinical Decision Area (CDA). The CDA is a short duration (\<24 hrs)) hospitalization unit,...
Eligibility Criteria
Inclusion
- Men and Women age greater than 18 year old
- Symptoms suggestive of an acute TIA
Exclusion
- Patients with contraindication to brain imaging: MRI and CT.
- Patient with persistent major deficit (NIHSS\> or = 4)
- Informed consent could not be obtained either directly from the patient or from legally authorized representative.
- Severe coexisting or terminal systemic disease with like expectancy below 90 days or that may interfere with the conduct of the study.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 2 2017
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT01423201
Start Date
September 1 2010
End Date
November 2 2017
Last Update
April 11 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Medical Center
Davis, California, United States
2
Stanford University School of Medicine
Stanford, California, United States, 94305
3
Michigan State University
Grand Rapids, Michigan, United States, 49503